OrioledHub’s New Cooperation

On August 17, 2022, Orioled Hub is very honored and proud of successfully signing an exclusive agreement with Seerpharma in Singapore. SeerPharma is a team of consultants that provide best-practice advice, training, software solutions from MasterControl, and contract labor resources to pharmaceutical, medical device and life science companies in the Asia-Pacific region on matters of Quality and GMP compliance. SeerPharma has been serving clients in the Asia-Pacific region for over 30 years from Melbourne, Sydney and Singapore and are also able to provide assistance in Europe through our affiliate in the UK.

Following the great success after more than two years of negotiation between Orioled Hub and Seerpharma, on August 22, 2022, Orioled Hub continues to successfully sign an exclusive agreement with Equilab. Equilab International is a leading Contract Research Organization (CRO) in Southeast Asia that provides bioavailability/bioequivalence study, clinical trials and analytical services. As the first CRO in Southeast Asia that is certified by WHO and UK-MHRA, they are in compliance with international GCP and GLP standards. Their study reports have been approved in UK, Netherland, Poland, Spain, Hungary, Afghanistan, Sri Lanka, Bangladesh, Hong Kong, Taiwan, and all Southeast Asia countries.

Orioled Hub hopes this cooperation will bring Vietnam’s pharmaceutical industry to a new level, also a turning point to help Orioled Hub get closer in its career to becoming the No. 1 company providing EU GMP services for all partners in Vietnam, in order to serve medicine users with valuable and quality products at reasonable prices.